Abstract. The effects of a number of steroid compounds on erythropoiesis in normal and polycythemic mice were examined. Of the steroids that stimulated erythropoiesis, the hormone testosterone and certain 513-H C19 and C21 nonhormonal metabolites were the most effective. Anti-erythropoietin abolished the erythropoiesis-stimulating effects of testosterone but not those exerted by the 53-H steroid, 1 1-ketopregnanolone. Similarly, testosterone but not 1 1-ketopregnanolone evoked the production of erythropoiesis-stimulating factor in rats. It is concluded that two mechanisms underlie the stimulating actions of steroids on erythropoiesis; one through the production of erythropoietin and the second involving a more direct influence on the blood-forming tissues. The 513-H steroid metabolites are postulated to act on erythropoiesis via the latter mechanism.
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Three mechanisms have been proposed for the effects exerted by steroids on mammalian erythropoiesis.1 One involves the capacity of certain steroids to influence production of the erythropoiesis-stimulating factor (ESF or erythropoietin),24 in some instances through an action on the production and release of the renal erythropoietic factor (REF or erythrogenin).l I An ability to alter the effectiveness of the ESF in stimulating erythropoiesis has been described as another possible mode of action of steroids.6-8 Evidence for a direct influence of steroids on the blood-forming tissues has also been presented.9-11 Of special interest in this regard is the recent demonstration of a potent stimulatory action of some 513-androstane and 513-pregnane steroids on heme synthesis in chick embryo liver cells and in the erythroid cell precursors of the chick blastoderm.12-15 The suggested mechanism for the steroid action described in the latter studies has involved the induction of 5-aminolevulinic acid synthetase, the rate-limiting enzyme in the heme biosynthetic pathway. An enhancing effect of a 513-H steroid metabolite on heme synthesis in vitro has also been recently described for human bone marrow cells. 16 The present study was undertaken to investigate the mechanisms underlying the influence of a series of natural steroids on erythropoiesis in mice and rats and to determine whether the ability of 513-H steroids to enhance avian hemoglobin synthesis extended to these mammalian species as well. 919 Two types of effects were obtained: (1) a stimulatory action on erythropoiesis due to an increased production of the ESF, as shown with testosterone, and (2) increased erythropoiesis via a mechanism not associated with heightened levels of the ESF as observed with 5(3-H C19 and C21 steroid metabolites. Evidence is presented that the latter mechanism probably involves a direct stimulatory action of the 5#-H steroid metabolite on erythroid cell precursors.
Materials and Methods. Studies in polycythemic mice: Adult female mice (CF-1 strain) rendered polycythemic by exposure to a lowered atmospheric pressure were used to determine the erythropoietic effects of six steroid compoundst (pregnanolone; 17a-OH, 11-ketoptegnanolone; l1-ketopregnanolone; etiocholanolone; 5(3-dihydrotestosterone; pregnandione). Each compound, administered as a single intraperitoneal injection, was tested at four dose levels (0.25, 0.75, 1.5, and 2.5 mg) dissolved in 0.1 ml of propylene glycol. The schedule of injections and estimation of erythropoietic activity were similar to those used in assessing ESF activity.-7
Studies in normal mice: The effects of testosterone, etiocholanolone, 11-ketoprenanolone, cortisol, and estradiol were determined on erythropoiesis in normal mice at three dose levels (0.25, 0.75, and 2.5 mg). Mice were injected intraperitoneally with a single dose on day 1 of the experiment and each received 0.5 k&Ci '9Fe Cl3 intravenously 48 hr later. The per cent incorporation of radioiron into the circulating red blood cells was determined on day 5 . As in polycythemic mice, 1 1-ketopregnanolone was found to be the most active in stimulating erythropoiesis. In subsequent experiments, therefore, this steroid and testosterone propionate were used exclusively. A similar study was performed in adult normal rats (Long-Evans strain) employing the latter two compounds.
Studies with anti-ESF: Six groups of normal mice (six mice/group) were established. The animals in group 1 were given intraperitoneal injections of 0.1 ml propylene glycol (the solvent vehicle for the steroids), while those in the second group received two daily intraperitoneal injections of 0.5 ml anti-ESF in addition to the 0.1 ml propylene glycol. Groups 3 and 4 were injected with a single 2.50 mg dose of testosterone propionate while those in groups 5 and 6 were given 2.50 mg of 11-ketopregnanolone. The mice in groups 4 and 6 also received two injections of 0.5 ml anti-ESF each. All mice were given intravenous injections of 0.5 MCi radioiron 48 hr after the administration of the steroid and the percentage of red blood cell radioiron incorporation values were determined 48 hr later. This method is now generally accepted as a reliable and sensitive index of the rate of erythropoiesis, paralleling the reticulocyte response to the same stimuli. '8 Experiments in rats: These studies were performed to determine the effects of testosterone propionate and 11-ketopregnanolone on the production of the ESF in adult female rats of the Long-Evans strain. The animals were injected intraperitoneally with 5.0 mg testosterone or with 2.5, 5.0, and 10 mg of 11-ketopregnanolone daily for four days. On day 5 the rats were killed by exsanguination and their plasmas collected, pooled separately, and assayed for ESF activity in exhypoxic polycythemic mice."7
Results. Experiments in mice: Table 1A indicates that single injections of a number of steroids resulted in augmented erythropoiesis, as judged by percentage of red blood cell 59Fe incorporation values, in normal adult mice.$ The most significant effects here as well as in exhypoxic polycythemic mice (Table  1B) were noted with 11-ketopregnanolone at all dose levels examined. As may be seen from Table 1B, control per cent red blood cell radioiron incorporation values were considerably lower in the exhypoxic polycythemic mice than in normal mice (Table 1A) . This marked depression in erythropoiesis occurs as a result of the negative feedback exerted by the excess numbers of red cells when the polycythemic mice are restored to ambient pressures. Such mice are known 5-B 17a-OH, 11-Ketopregnanolone 2.4 ± 0.2 2.7 ± 0.4 S3.4 4± 1.5 6.7 ± 1.8
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6. 3 ± 1.5 2.9 ±t0. to respond more sensitively to erythropoietic stimuli, as for example the ESF.5 Table 1B indicates that, as in normal mice, li-ketopregnanolone increased the red blood cell radioiron incorporation values in polycythemic mice to a greater extent than did the other steroids tested. Etiocholanolone was stimulatory at the 0.25 mg level in normal mice and at the four levels tested in polycythemic mice. A reduction in the red blood cell radioiron incorporation values was noted with the 2.5 mg dose in normal mice. The reason for this is not clear but higher concentrations of certain 5,B-steroids have been shown to have similar effects on porphyrinogenesis in liver cell culture, presumably due to toxic effects of the steroids on the cells. Testosterone administration led to a mild increase in erythropoiesis at the 2.5 mg dose level (Table 1A) . As previously shown,20 estradiol inhibited erythropoiesis in normal mice, an effect seen most significantly in this study at the 2.5 mg dose level. Somewhat similar inhibitory effects were noted with cortisol (Table 1A) . Table 2 shows the action of anti-ESF serum on the stimulatory effects evoked by steroids on erythropoiesis in normal mice. Two injections of anti-ESF markedly depressed erythropoiesis in these otherwise untreated animals indicating that normal erythropoiesis is largely under control of the ESF. Anti-ESF completely abolished the erythropoiesis-stimulatory influence of testosterone; however, it exerted only a slight, statistically insignificant (P = 0.2), depressive action on the erythropoietic effect of 11-ketopregnanolone. Similar results not indicated in the tables were obtained when transfusion-induced plethoric mice2 5 were used instead of normal mice. Here, although the red blood cell radioiron incorporation values were as expected much lower than in normal mice), the effects were in the same direction and statistically significant. These results are consistent with the interpretation that the erythropoietic action of 5,3-H steroids is mediated largely via a non-ESF mechanism as suggested earlier.'2 Table 3 demonstrates that stimulatory effects on both 24-and 48-hour red blood cell radioiron incorporation values in adult rats were exerted by four daily injections of three different doses (2.5, 5.0, and 10.0 mg) of 11-ketopregnanolone. The most significant influence was seen in the rats receiving the 5.0 mg dose. Erythropoiesis was also significantly increased by four daily injections of testosterone, as expected. Table 4 lists the results for the assay of ESF in plasma from the five groups of rats shown in Table 3 . Hypoxia-induced polycythemic mice were used as the test animals.2 It will be noted that marked stimulatory effects on red blood cell radioiron incorporation were observed with plasma from testosterone-treated rats. That this plasma activity was due to ESF evoked by testosterone was seen from our unpublished findings that prior treatment of this plasma with anti-ESF resulted in complete loss of its erythropoietic activity. In contrast, the plasma from rats receiving the three different dose levels of 11-ketopregnanolone was devoid of erythropoiesis-stimulating activity. 1.1 i 0.3 Plasma from propylene glycol-treated rats 2.1 =1: 0.5 Plasma from testosterone-treated rats 11.7 i 2.0 Plasma from 11-ketopregnanolone-treated rats Rats given 2.5mg X 4 2.1 4±0.6 Rats given 5.0mg X 4
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t Standard error of the mean.
Discussion. The present experiments indicate that at least two different mechanisms underlie the erythropoietic actions of steroids and certain of their derivatives. It has been demonstrated previously that testosterone stimulates red cell formation in rodents2 3' 5-7 and in man2l and that this is achieved, at least in part, by augmenting production of the ESF.2 3 5 21. 22 The experiments reported here confirm these findings in testosterone-treated rats. Additional evidence for this concept is derived from the ability of anti-ESF to completely abolish the erythropoiesis-stimulating action of testosterone (ref. 23 and the present paper). § On the other hand, as shown in these experiments, the erythropoiesis-stimulating action of the 513-pregnane compound 11-ketopregnanolone was not accompanied by an elevated level of circulating ESF, a finding that also receives support from our observation that its effects were not antagonized by anti-ESF. In view of the ability of 513-H, C19, and C21 steroids to directly stimulate hemoglobin synthesis in cultured chick blastoderms'2 and porphyrin-heme synthesis both in vivo and in vitro in chick embryo liver,13-15 as well as to enhance heme production in cultured human bone marrow cells,16 it seems highly probable that the effects of these 513-H steroids on erythropoiesis in the mouse are exerted directly on the blood-forming tissues in vivo.
Testosterone has been noted to be weakly active, when compared to a series of 513-H androstane and pregnane compounds, in stimulating heme synthesis in chick blastoderms and chick embryo liver cells in vitro.14 Similarly, in the present study, testosterone proved to be less effective than 513-H metabolites in augmenting erythropoiesis in both normal and plethoric mice. It is known that transfusion-induced plethora in the mouse induces a virtual disappearance of the nucleated erythroid cell compartment. Since the 513-H steroid metabolites utilized in this study were shown not to stimulate ESF production, it would appear likely that their primary effect is exerted directly on the early erythroid cell precursors, inducing them to differentiate into the nucleated erythroid cell line. It is reasonable to postulate that, as for the hepatic and erythroid cell lines of the chick embryo, these steroids act by inducing the formation of 3-aminolevulinic acid synthetase in erythroid cell precursors of the mouse, thus leading to enhanced formation of heme and subsequently of hemoglobin in these elements. Of interest are recent findings24 that ESF also enhances 6-aminolevulinic acid synthetase activity in rabbit bone marrow cells in vitro, suggesting the possibility
